News New NICE rules could deny drugs to rare disease patients Patients could be denied treatments, says BIA
News Shire fined $350m for skin product bribes Settlement relates to investigation into Dermagraft sales.
News Intercept's Ocaliva approved in EU for liver disease Potential liver blockbuster gets EU licence.
News NICE rejects Shire pancreatic cancer drug Onivyde not eligible for Cancer Drugs Fund, says NICE.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
